psychosis or early onset of neurological problems,” said Paul Hagerman, professor of biochemistry and molecular medicine at UC Davis and co-author on the study. “This understanding helps develop treatment plans that address the multiple needs of these patients.”For the study, the research team looked at 14 cases of male patients with FMR1-gene mutations and a variety of psychiatric disorders.
These patients, ages ranging between nine and 58 years, had features resembling FXS and symptoms common among premutation carriers.FXS symptoms include hand flapping, hyperactivity, recurrent ear infections, severe anxiety and tantrums.
Read more on psychcentral.com